Related scientific articles (all)

Vulvar metastasis from bladder cancer.

Authors : Aoun F, El Rassy E, Kourie HR, Hawaux E, Van Velthoven R
Year : 2015
Journal : Case Rep Obstet Gynecol
Volume : 2015
Pages : 324634

Results of a phase II study of bendamustine and ofatumumab in untreated indolent B cell non-Hodgkin's lymphoma.

Authors : Czuczman MS, Kahanic S, Forero A, Davis G, Munteanu M, Van Den Neste E, Offner F, Bron D, Quick D, Fowler N
Year : 2015
Journal : Ann Hematol
Volume : 94(4)
Pages : 633-41

'New' metastases are associated with a poorer prognosis than growth of pre-existing metastases in patients with metastatic breast cancer treated with chemotherapy, Breast Cancer Research 2015, 17: 150

Authors : Twelves C, Cortes J, Kaufman PA, Yelle L, Awada A, Binder T, Olivo M, O Shaughnessy J, Jove M, Perez EA
Year : 2015
Journal : Breast Cancer Res
Volume : 17
Pages : 150

Acute respiratory failure in patients with hematological malignancies: outcomes according to initial ventilation strategy. A groupe de recherche respiratoire en réanimation onco-hématologique (Grrr-OH) study.

Authors : Lemiale V, Resche-Rigon M, Mokart D, Pène F, Rabbat A, Kouatchet A, Vincent F, Bruneel F, Nyunga M, Lebert C, Perez P, Meert AP, Benoit D, Chevret S, Azoulay E
Year : 2015
Journal : Ann Intensive Care
Volume : 5
Pages : 28

Evolving paradigms in multifocal breast cancer.

Authors : Salgado R, Aftimos P, Sotiriou C, Desmedt C
Year : 2015
Journal : Semin. Cancer Biol.
Volume : 31C
Pages : 111-118

Prophylaxis of febrile neutropenia in adults receiving chemotherapy needs to be adapted to the risk.

Authors : Georgala A, Klastersky J
Year : 2015
Journal : Expert Rev Hematol
Volume : 8(1)
Pages : 115-21

Benefit to neoadjuvant anti-human epidermal growth factor receptor 2 (HER2)-targeted therapies in HER2-positive primary breast cancer is independent of phosphatase and tensin homolog deleted from chromosome 10 (PTEN) status.

Authors : Nuciforo PG, Aura C, Holmes E, Prudkin L, Jimenez J, Martinez P, Ameels H, de la Peña L, Ellis C, Eidtmann H, Piccart-Gebhart M, Scaltriti M, Baselga J
Year : 2015
Journal : Ann Oncol
Volume : 26
Pages : 1494-500

Has the time come for genomic tests to guide the use of adjuvant chemotherapy in node-positive breast cancer?

Authors : Azim HA
Year : 2015
Journal : Ann Oncol
Volume : 26(8)
Pages : 1521-3

Enabling semantic interoperability in multi-centric clinical trials on breast cancer.

Authors : Alonso-Calvo R, Perez-Rey D, Paraiso-Medina S, Claerhout B, Hennebert P, Bucur A
Year : 2015
Journal : Comput Methods Programs Biomed
Volume : 118(3)
Pages : 322-329

Constitutive phosphorylated STAT3-associated gene signature is predictive for trastuzumab resistance in primary HER2-positive breast cancer.

Authors : Sonnenblick A, Brohée S, Fumagalli D, Vincent D, Venet D, Ignatiadis M, Salgado R, Van den Eynden G, Rothé F, Desmedt C, Neven P, Loibl S, Denkert C, Joensuu H, Loi S, Sirtaine N, Kellokumpu-Lehtinen PL, Piccart-Gebhart M, Sotiriou C
Year : 2015
Journal : BMC Med
Volume : 13(1)
Pages : 177

Discrepancies between ESMO and NCCN breast cancer guidelines: An appraisal.

Authors : Zagouri F, Liakou P, Bartsch R, Peccatori FA, Tsigginou A, Dimitrakakis C, Zografos GC, Dimopoulos MA, Azim HA
Year : 2015
Journal : Breast
Volume : 24(4)
Pages : 513-23

Thrombo-embolic events in cancer patients with impaired renal function

Authors : Elalamy I, Canon JL, Bols A, Lybaert W, Duck L, Jochmans K, Bosquée L, Peeters M, Awada A, Clement P, Holbrechts S, Baurain JF, Mebis J, Nortier J
Year : 2015
Journal : Belgian J Medical Oncology
Volume : 9(2)
Pages : 53-60

Idarubicin and cytarabine in combination with gemtuzumab ozogamicin (IAGO) for untreated patients with high-risk MDS or AML evolved from MDS: a phase II study from the EORTC and GIMEMA Leukemia Groups (protocol 06013).

Authors : de Witte T, Suciu S, Meert L, Halkes C, Selleslag D, Bron D, Amadori S, Willemze R, Muus P, Baron F
Year : 2015
Journal : Ann Hematol
Volume : 94
Pages : 1981-9

A joint model for the dependence between clustered times to tumour progression and deaths: A meta-analysis of chemotherapy in head and neck cancer.

Authors : Rondeau V, Pignon JP, Michiels S
Year : 2015
Journal : Stat Methods Med Res
Volume : 24
Pages : 711-29

Spurious decrease in the WBC count measured by the WNR channel of XN haematology analyser (Sysmex) could be associated with metastatic adenocarcinoma.

Authors : Nguyen VT, Gobin D, Li R, Cantinieaux B
Year : 2015
Journal : Int J Lab Hematol
Volume : 37(5)
Pages : e129-32

Final 10-year results of the Breast International Group 2-98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer.

Authors : Sonnenblick A, Francis PA, Azim HA, de Azambuja E, Nordenskjöld B, Gutiérez J, Quinaux E, Mastropasqua MG, Ameye L, Anderson M, Lluch A, Gnant M, Goldhirsch A, Di Leo A, Barnadas A, Cortes-Funes H, Piccart-Gebhart M, Crown J
Year : 2015
Journal : Eur. J. Cancer
Volume : 51(12)
Pages : 1481-9

Targeted agents for cancer treatment during pregnancy.

Authors : Lambertini M, Peccatori FA, Azim HA
Year : 2015
Journal : Cancer Treat Rev
Volume : 41(4)
Pages : 301-309

Utility of Next-Generation Sequencing in Cancer Drug Development and Clinical Trials, Next Generation Sequencing in Cancer Research 2015,

Authors : Thomas F, Awada A
Year : 2015
Journal : Book
Volume : 2
Pages : 19-37

Cardiac assessment of early breast cancer patients 18years after treatment with cyclophosphamide-, methotrexate-, fluorouracil- or epirubicin-based chemotherapy.

Authors : de Azambuja E, Ameye L, Diaz M, Vandenbossche S, Aftimos P, Hernández SB, Shih-Li C, Delhaye F, Focan C, Cornez N, Vindevoghel A, Beauduin M, Lemort M, Paesmans M, Suter T, Piccart-Gebhart M
Year : 2015
Journal : Eur J Cancer
Volume : 51
Pages : 2517-24

IRF5: a rheostat for tumor-infiltrating lymphocyte trafficking in breast cancer?

Authors : Garaud S, Willard-Gallo K
Year : 2015
Journal : Immunol. Cell Biol.
Volume : 93(5)
Pages : 425-6